In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty
Paul K. Paik, MD
Clinical Director, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY, United States
Consulting Fees: ACE Oncology, Crown Bioscience Inc., EMD Serono Inc., Medscape, Mirati Therapeutics, Novartis, PER Events, LLC, Research To Practice, Takeda Pharmaceuticals
D. Ross Camidge, MD, PhD
Director, Thoracic Oncology
University of Colorado
Aurora, CO, United States
Consulting Fees: AbbVie, Anheart, Beigene, Eli Lilly, Imagene, Immunocore, Janssen, Mirati, Prelude, Seattle Genetics, Valence
Contracted Research: AstraZeneca, Blueprint, Dizal, Inhibrx, Karyopharm, Nuvalent, Pfizer, Phosplatin, Psioxus, Rain, Roche/Genentech, Seattle Genetics, Takeda, Turning Point, Verastem
Reviewers/Content Planners/Authors:
- Jorge Bacigalupo has nothing to disclose.
- Cindy Davidson has nothing to disclose.
- Ann Early has nothing to disclose
- Amanda Hilferty has nothing to disclose.
- Libby Lurwick has nothing to disclose.
- Tim Person has nothing to disclose.
- Keith Kerr, BSc, MB ChB disclosures to come.
Facebook Comments